医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Aethon Debuts the T4 Autonomous Mobile Robot at MOTEK 2018

2018年10月05日 AM05:34
このエントリーをはてなブックマークに追加


 

PITTSBURGH

Aethon is expanding its line of autonomous mobile robots (AMRs) and will unveil the newest TUG robot, the T4, at MOTEK 2018 in Stuttgart, Germany. Aethon can be found in Hall 7 at booth 7420.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181004005158/en/

The T4 is the answer for industrial, manufacturing and logistics customers who need a smaller, faster and integration-ready mobile robot. System integrators and distributors will value the T4 as an improved mobility platform due to its ease of deployment, cost-effectiveness and open connectivity options.

The T4 builds on Aethon’s TUG product line by providing system integrators greater flexibility through its built-in connections to allow the integration of active payloads such as tools or conveyors. Aethon will be encouraging third parties to develop solutions to pair with the T4 platform. As a catalyst and example for developers, at MOTEK 2018, Aethon will demonstrate a powered conveyor attached to its mobile chassis interacting with fixed automation equipment. The T4 will pair with existing automation equipment even in tight spaces due to its center-pivot 17 inch / 44 cm turning radius. It will haul loads up to 250 lbs / 113 kg and is capable of traveling on sloped areas up to 5 degrees thanks to its unique independent suspension system. The T4 can also travel at speeds up to 2 m/s. It will automatically pick up and drop off carts, avoiding the labor costs of cart-tending required by competing AMRs.

“The T4 is a big step forward for Aethon in the industrial segment. The needs of our manufacturing customers, integrators and distributors drove this innovation and we are thankful for the insight they provided. We are excited to add T4’s open platform design to our existing product line, giving our customers a wide range of capabilities in industrial settings,” says Aldo Zini, CEO of Aethon.

Like all of Aethon’s AMRs, the T4 will autonomously navigate a facility using pre-defined maps and routes along with delivery and pickup points. It does not require complex or fixed infrastructure and can be installed easily in a facility with existing Wi-Fi coverage. The T4 leverages Aethon’s existing fleet management capabilities to ensure an installation with a multitude of robots will scale and is operationally efficient. The T4 also integrates with building systems and elevators, and retains the safety and reliability track record for which Aethon is known. All of these advantages result in a faster ROI and more reliable operations.

About Aethon

Aethon, a company of Vision Technologies Systems, Inc. (VT Systems), is the leading autonomous mobile delivery robot and automates internal logistics in manufacturing, hospitals, and hospitality settings by delivering goods and supplies using its TUG autonomous mobile robot. For more information, visit www.aethon.com

VT Systems is an engineering company providing integrated solutions to the commercial and government markets in the aerospace, electronics, land systems and marine sectors. VT Systems’ innovative solutions, products and services include aircraft maintenance, repair and modification; software solutions in training and simulation; satellite based IP communications technology; network solutions that integrate data, voice and video; rugged computers and computer peripheral equipment; specialized truck bodies and trailers; weapons and munitions systems; road construction equipment; and ship design and shipbuilding. Headquartered in Alexandria, Va., VT Systems operates globally and is a wholly owned subsidiary of ST Engineering. Please visit www.vt-systems.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181004005158/en/

CONTACT

Aethon
Tony Melanson, 412-322-2975
VP Marketing
Tmelanson@aethon.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Takeda Announces Listing of American Depositary Shares on the New York Stock Exchange
  • 武田获得CHMP肯定意见,接纳ADCETRIS® (brentuximab vedotin)联合AVD用于治疗既往未曾治疗的CD30+ IV期霍奇金淋巴瘤成人患者
  • 富士制药向Alvotech投资5000万美元
  • 武田薬品、未治療のCD30陽性ステージ4ホジキンリンパ腫成人患者を治療するためのアドセトリス(ブレンツキシマブ・ベドチン)とAVDの併用に関するCHMPの肯定的見解を受領
  • AVITA Medical Announces Receipt of A$1.4 Million Research and Development Tax Credit